Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - estradiol hemihydrate, quantity: 1.54 mg (equivalent: estradiol, qty 1.5 mg) - drug delivery system, transdermal - excipient ingredients: isopropyl palmitate; polyethylene terephthalate; ethyl acetate; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; hexane - menopausal symptoms: short-term treatment of signs and symptoms of oestrogen deficiency due to menopause, whether natural or surgically induced. in women with an intact uterus, oestrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals (refer to section 5.1 pharmacodynamic properties - clinical trials and section 4.2 dose and method of administration). prevention of post-menopausal bone mineral density loss: estraderm mx 50, 75 and 100 may be used for prevention of post-menopausal bone mineral density loss in women with an increased risk of future osteoporotic fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of bone mineral density loss. when prescribed solely for the prevention of postmenopausal bone mineral density loss, therapy should only be prescribed for women who are at high risk of future fracture and who are intolerant of, or contraindicated for, non-oestrogen products approved for prevention of bone mineral density loss. lifestyle modifications and the risk-benefit profile of estraderm mx should be taken into careful consideration and discussed with the patient to allow the patient to make an informed decision prior to prescribing (see section 4.4 special warnings and precautions for use and sectoin 4.2 dose and method of administration). combination hrt should not be used in hysterectomised women because it is not needed in these women and it may increase risk of breast cancer.

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

wyeth pharmaceuticals, inc. - desvenlafaxina (succinato monohidrato) - desvenlafaxina (succinato monohidrato)....50.0 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - calcium folinate 108mg - powder for injection - 100 mg - active: calcium folinate 108mg

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - calcium folinate 378mg - powder for injection - 350 mg - active: calcium folinate 378mg excipient: hydrochloric acid sodium chloride sodium hydroxide

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - calcium folinate 54mg - powder for injection - 50 mg - active: calcium folinate 54mg

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - calcium folinate 10 mg/ml - solution for injection - 10 mg/ml - active: calcium folinate 10 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - calcium folinate 3.24 mg/ml - solution for injection - 3 mg/ml - active: calcium folinate 3.24 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - calcium folinate 3.24 mg/ml equivalent to to 3 mg folinic acid. - solution for injection - 3 mg/ml - active: calcium folinate 3.24 mg/ml equivalent to to 3 mg folinic acid. excipient: benzyl alcohol water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - calcium folinate 12.71mg (to give 10mg anhydrous leukovorin free acid.) - tablet - 10 mg - active: calcium folinate 12.71mg (to give 10mg anhydrous leukovorin free acid.) excipient: lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate starch

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - calcium folinate 19.06mg equivalent to 15 mg folinic acid - tablet - 15 mg - active: calcium folinate 19.06mg equivalent to 15 mg folinic acid excipient: lactose monohydrate magnesium stearate microcrystalline cellulose pregelatinised maize starch sodium starch glycolate